Remidio

28/11/2025

Our 16th Anniversary Townhall wasn’t just a celebration; it was a reflection of how far passion, purpose, and people can take us. Every handshake, every laugh, every story shared that day captured the essence of true collaboration and collective vision. Gratitude to everyone who’s been part of this journey toward accessible eye care for all.

Here’s to a milestone that reminds us why we started and inspires us to keep building the future, one clear vision at a time. 👁✨

27/11/2025

Remidio is proud to be named one of the Top 10 global finalists at the Asian Development Bank’s AIDEA Tech Challenge 2025!

Selected from innovators worldwide, Remidio will showcase Medios HI at the AIDEA Tech Challenge Grand Finale on 28 November 2025 at ADB Headquarters in Manila.

Co-led by Asia Development Bank and PATH, this event will bring together innovators, global experts, policymakers, investors, and development partners focused on advancing equitable access to diagnostics in Asia and the Pacific.

This recognition underscores Remidio’s commitment to building responsible, accessible, affordable and scalable AI solutions that strengthen health systems globally.

Proudly representing India on the global stage. 🇮🇳✨

25/11/2025

This Karnataka Rajyotsava, we went all out — colour, culture, energy, everything!
Our celebration turned into a full-on cultural fest, complete with the powerful beats of Yakshagana, vibrant dance performances, and a team that knows how to bring the house down with joy and spirit.

From loud laughter to lively rhythms, every moment felt like Karnataka at its brightest — bold, creative, and full of life.
Huge cheers to our incredible team for making the day unforgettable, and for carrying the same passion into everything we do.

Here’s to the culture that inspires us, the people who uplift us, and the energy that keeps us moving forward.

25/11/2025

We're excited to be showcasing two technologies setting new global benchmarks!
Meet Remidio at EPOMEC, Dubai and World ROP Congress, Florence – where we’ll be displaying:

• The world's 1st smartphone-based non-mydriatic fundus camera
• The world's 1st AI-enabled pediatric ultra-widefield retinal imaging system

If you're passionate about advancing eye care accessibility, precision diagnostics, and AI-powered innovation, this is where you need to be.

📍 EPOMEC – Dubai World Trade Center
🗓 4th – 6th December 2025
🔶 Zone C, Stall C3

📍 World ROP Congress – Fortezza da Basso, Florence
🗓 4th – 5th December 2025
🔶 Stall 4A

Join us at our booth! To secure a personalized live demo, comment “Interested” and we’ll arrange your slot during the event.

23/11/2025

Meet our Speaker for the Remidio & Orbis Cybersight Webinar, Dr. Anand Vinekar, Ophthalmologist, Narayana Nethralaya Eye Institute, India, on “Saving Sight in Preemies: Scalable ROP Screening for Public Health.”

Join us for an insightful session with Dr. Anand Vinekar, a global leader in neonatal eye care and the driving force behind the pioneering KIDROP initiative. Drawing on over a decade of field experience, Dr. Vinekar will share how AI-enabled tools, mobile imaging technologies, and tele-ROP networks are transforming screening and treatment for retinopathy of prematurity (ROP)—especially in resource-limited settings.

Learn how scalable, technology-driven models are enabling early detection, equitable access, and sustainable prevention of childhood blindness.

Don’t miss this opportunity to learn from one of the leading voices in ROP and public health innovation!

Registration link- https://zurl.co/m2uiP

20/11/2025

A complimentary eye screening camp was conducted at Mr. Dinesh Gundu Rao’s office on the occasion of Smt. Indira Gandhi’s birth anniversary, bringing together the U Be Good Foundation, Remidio, and Narayana Nethralaya.

Using the Pristine VX 650, screenings were carried out for pourakarmikas, recognising the individuals who work tirelessly.

This initiative reflects our shared commitment to accessible and preventive eye care at the grassroots level.

We thank Mr. Dinesh Gundu Rao, Minister of Health & Family Welfare, Karnataka, for his support in enabling this meaningful effort.

20/11/2025

Remidio has been featured in The Times of India in an important article authored by Dr Kalpa Negolini, our Clinical Head, on eye issues in newborns and young children.

Early detection saves sight, and it is encouraging to see mainstream platforms highlight the need for accessible, high-quality eye screening.

Grateful to be part of a mission that supports parents, clinicians, and communities in protecting children’s vision.

https://zurl.co/S0BS6

Parents, be vigilant! Subtle signs in your baby's eyes, like unusual reflections or misaligned movements, can signal serious issues. Early detection o

19/11/2025

Dr. Anand Vinekar sheds light on why Retinopathy of Prematurity (ROP) isn’t just an ophthalmic condition; it’s a pressing public health challenge that affects neonatal care systems globally.

From neonatologists monitoring premature infants to nurses in NICUs and public health officials shaping maternal and child health programs, every healthcare professional plays a vital role in early detection and timely intervention.

ROP prevention and management demand a collaborative, technology-enabled approach that extends beyond specialized eye clinics. With innovations like AI-assisted image interpretation, mobile screening devices, and integrated tele-ROP networks, the landscape of neonatal eye care is rapidly evolving.

Join Dr. Anand Vinekar in our upcoming webinar to explore how scalable, technology-driven ROP screening is transforming outcomes for premature infants in resource-limited settings.

Registration link- https://zurl.co/F0eAp

17/11/2025

A proud moment at the World ROP Day press meet with leaders from Narayana Nethralaya and the KIDROP program. Remidio shared Neubo 130, our AI enabled ROP camera designed for real time screening and wider access across India developed in partnership with KIDROP. Together we work toward protecting every premature infant’s right to sight.

Left to right
Sk Mittal - CEO of Narayan Nethralaya, Dr Naren Shetty - Director of NN,
Dr Anand Vinekar - Founder Program Director KIDROP, Manohar D Chatlani - Trustee, Have a Heart Foundation, Dr Anand Sivaraman, CEO and Director Remidio

17/11/2025

We are pleased to share that our CEO, Dr Anand Sivaraman, will speak as a panelist at the 28th Bengaluru Tech Summit 2025, Asia’s largest and most influential technology event.

With the theme Futurise, this year’s summit will bring together global leaders, innovators, and visionaries shaping the future of science, technology, and healthcare.

Anand will join a distinguished panel to discuss the evolving landscape of diagnostics and medtech, and the innovations transforming healthcare delivery.

We look forward to contributing to meaningful and future focused discussions.

17/11/2025

On this Prematurity Day, Remidio stands at the forefront of early intervention with our advanced ROP screening technology. By enabling healthcare professionals to detect and prevent vision loss in premature babies, we’re helping to ensure brighter futures, one scan at a time.

Join us in supporting a future where every preterm baby has the chance to thrive.